Total Payments
$1,584
2024 Payments
$153.79
Companies
7
Transactions
15
Medicare Patients
2,344
Medicare Billing
$271,692
Payment Breakdown by Category
Food & Beverage$798.97 (50.4%)
Travel$784.88 (49.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $798.97 | 11 | 50.4% |
| Travel and Lodging | $784.88 | 4 | 49.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $953.50 | 6 | $0 (2017) |
| GENZYME CORPORATION | $169.06 | 3 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $127.87 | 1 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $119.70 | 1 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $100.55 | 1 | $0 (2020) |
| CSL Behring | $79.08 | 2 | $0 (2017) |
| Veloxis Pharmaceuticals, Inc. | $34.09 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $153.79 | 2 | Alexion Pharmaceuticals, Inc. ($119.70) |
| 2022 | $127.87 | 1 | SANOFI-AVENTIS U.S. LLC ($127.87) |
| 2020 | $100.55 | 1 | Mallinckrodt Hospital Products Inc. ($100.55) |
| 2017 | $1,202 | 11 | Novartis Pharmaceuticals Corporation ($953.50) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/25/2024 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $34.09 | General |
| Category: TRANSPLANTATION | ||||||
| 06/01/2024 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Food and Beverage | In-kind items and services | $119.70 | General |
| Category: Rare Disease | ||||||
| 06/05/2022 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Food and Beverage | In-kind items and services | $127.87 | General |
| Category: Oncology | ||||||
| 03/12/2020 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $100.55 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2017 | GENZYME CORPORATION | THYMOGLOBULIN (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2017 | GENZYME CORPORATION | THYMOGLOBULIN (Drug) | Food and Beverage | In-kind items and services | $113.66 | General |
| Category: ONCOLOGY | ||||||
| 10/03/2017 | GENZYME CORPORATION | THYMOGLOBULIN (Drug) | Food and Beverage | In-kind items and services | $35.72 | General |
| Category: ONCOLOGY | ||||||
| 08/25/2017 | Novartis Pharmaceuticals Corporation | ZORTRESS (Drug) | Travel and Lodging | In-kind items and services | $146.90 | General |
| Category: IMMUNOLOGY | ||||||
| 08/25/2017 | Novartis Pharmaceuticals Corporation | ZORTRESS (Drug) | Food and Beverage | In-kind items and services | $123.64 | General |
| Category: IMMUNOLOGY | ||||||
| 08/25/2017 | Novartis Pharmaceuticals Corporation | ZORTRESS (Drug) | Food and Beverage | Cash or cash equivalent | $44.98 | General |
| Category: IMMUNOLOGY | ||||||
| 08/25/2017 | Novartis Pharmaceuticals Corporation | ZORTRESS (Drug) | Travel and Lodging | Cash or cash equivalent | $30.98 | General |
| Category: IMMUNOLOGY | ||||||
| 08/25/2017 | Novartis Pharmaceuticals Corporation | ZORTRESS (Drug) | Travel and Lodging | In-kind items and services | $20.00 | General |
| Category: IMMUNOLOGY | ||||||
| 08/24/2017 | Novartis Pharmaceuticals Corporation | ILARIS (Biological), ZORTRESS | Travel and Lodging | In-kind items and services | $587.00 | General |
| Category: IMMUNOLOGY | ||||||
| 04/20/2017 | CSL Behring | Berinert 500U (Biological) | Food and Beverage | In-kind items and services | $55.08 | General |
| Category: Critical Care | ||||||
| 04/20/2017 | CSL Behring | Berinert 500U (Biological) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Critical Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 411 | 591 | $175,371 | $49,966 |
| 2022 | 8 | 534 | 801 | $255,456 | $68,925 |
| 2021 | 10 | 668 | 972 | $303,315 | $79,755 |
| 2020 | 11 | 731 | 1,059 | $285,567 | $73,045 |
Total Patients
2,344
Total Services
3,423
Medicare Billing
$271,692
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 166 | 218 | $76,082 | $20,781 | 27.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 35 | 84 | $24,948 | $7,608 | 30.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 51 | 124 | $26,040 | $7,441 | 28.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 40 | 44 | $10,824 | $3,466 | 32.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 25 | 25 | $12,375 | $3,328 | 26.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 50 | 50 | $12,300 | $3,168 | 25.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 15 | $5,235 | $1,768 | 33.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 13 | $4,381 | $1,296 | 29.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 18 | 18 | $3,186 | $1,109 | 34.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 181 | 241 | $84,109 | $27,043 | 32.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 83 | 247 | $73,359 | $19,048 | 26.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 81 | 83 | $20,418 | $5,944 | 29.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 40 | 74 | $15,540 | $4,046 | 26.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 25 | 26 | $12,870 | $3,754 | 29.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 43 | 46 | $11,316 | $3,378 | 29.8% |
| 50200 | Needle biopsy of kidney | Facility | 2022 | 22 | 22 | $24,970 | $2,085 | 8.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 13 | $4,537 | $1,586 | 35.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 26 | 28 | $4,956 | $1,553 | 31.3% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2022 | 21 | 21 | $3,381 | $488.47 | 14.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 181 | 224 | $78,176 | $25,351 | 32.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 65 | 202 | $59,994 | $16,342 | 27.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 154 | 167 | $41,082 | $12,091 | 29.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 65 | 168 | $35,280 | $8,948 | 25.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 35 | 40 | $19,800 | $5,965 | 30.1% |
| 50200 | Needle biopsy of kidney, accessed through the skin | Facility | 2021 | 38 | 38 | $43,130 | $3,822 | 8.9% |
About Clifton Kew
Clifton Kew is a Nephrology healthcare provider based in Birmingham, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851328702.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Clifton Kew has received a total of $1,584 in payments from pharmaceutical and medical device companies, with $153.79 received in 2024. These payments were reported across 15 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($798.97).
As a Medicare-enrolled provider, Kew has provided services to 2,344 Medicare beneficiaries, totaling 3,423 services with total Medicare billing of $271,692. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Birmingham, AL
- Active Since 06/27/2006
- Last Updated 02/02/2024
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1851328702
Products in Payments
- ILARIS (Biological) $587.00
- ZORTRESS (Drug) $366.50
- THYMOGLOBULIN (Drug) $169.06
- THYMOGLOBULIN (Biological) $127.87
- SOLIRIS (Biological) $119.70
- ACTHAR (Biological) $100.55
- Berinert 500U (Biological) $79.08
- ENVARSUS (Drug) $34.09
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Birmingham
David Warnock, Md, MD
Nephrology — Payments: $186,004
Nephrology $186,004
Eric Wallace
Nephrology — Payments: $137,132
Nephrology $137,132
Dana Rizk
Nephrology — Payments: $124,680
Nephrology $124,680
Michal Mrug
Nephrology — Payments: $92,833
Nephrology $92,833
Ashita Tolwani
Nephrology — Payments: $67,643
Nephrology $67,643
Timmy Lee
Nephrology — Payments: $38,311
Nephrology $38,311